Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Breton

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Diabetes Technology & Therapeutics|March 17, 2023
Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose Control in Children with Type 1 Diabetes Compared to Sensor-Augmented Pump TherapyRégis Coutant, Elise Bismuth, Elisabeth Bonnemaison, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP SystemsRichard M Bergenstal, Adam Heller, Marc D Breton, et al.
Diabetes Technology & Therapeutics|July 1, 2025
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery SystemsPeter G Jacobs, Carol J Levy, Sue A Brown, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery SystemsPeter G Jacobs, Carol J Levy, Sue A Brown, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
A nationwide 12-month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe eventsJean-Pierre Riveline, Jean-Baptiste Julla, Elisabeth Bonnemaison, et al.
The New England Journal of Medicine|August 27, 2020
A Randomized Trial of Closed-Loop Control in Children with Type 1 DiabetesMarc D Breton, Lauren G Kanapka, Roy W Beck, et al.
Diabetes Technology & Therapeutics|February 6, 2026
Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled TrialAnas El Fathi, Ralf Nass, Carol J Levy, et al.
Diabetes Care|December 23, 2020
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 DiabetesLauren G Kanapka, R Paul Wadwa, Marc D Breton, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2017
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 DiabetesSue A Brown, Marc D Breton, Stacey M Anderson, et al.
Diabetes Care|June 16, 2014
Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreasBoris P Kovatchev, Eric Renard, Claudio Cobelli, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Diabetes Technology & Therapeutics|March 17, 2023
Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose Control in Children with Type 1 Diabetes Compared to Sensor-Augmented Pump TherapyRégis Coutant, Elise Bismuth, Elisabeth Bonnemaison, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP SystemsRichard M Bergenstal, Adam Heller, Marc D Breton, et al.
Diabetes Technology & Therapeutics|July 1, 2025
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery SystemsPeter G Jacobs, Carol J Levy, Sue A Brown, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery SystemsPeter G Jacobs, Carol J Levy, Sue A Brown, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
A nationwide 12-month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe eventsJean-Pierre Riveline, Jean-Baptiste Julla, Elisabeth Bonnemaison, et al.
The New England Journal of Medicine|August 27, 2020
A Randomized Trial of Closed-Loop Control in Children with Type 1 DiabetesMarc D Breton, Lauren G Kanapka, Roy W Beck, et al.
Diabetes Technology & Therapeutics|February 6, 2026
Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled TrialAnas El Fathi, Ralf Nass, Carol J Levy, et al.
Diabetes Care|December 23, 2020
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 DiabetesLauren G Kanapka, R Paul Wadwa, Marc D Breton, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2017
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 DiabetesSue A Brown, Marc D Breton, Stacey M Anderson, et al.
Diabetes Care|June 16, 2014
Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreasBoris P Kovatchev, Eric Renard, Claudio Cobelli, et al.
Pageof 19